Improved Synthesis of Dbibb as a New Anti-Radiation Agent

An excellent candidate in the fight against damage caused by nuclear radiation is 2-[4-(1,3-dioxo-1H,3Hbenzoisoquinolin-2-yl)butylsulfamoyl]benzoic acid (DBIBB), a lipid agonist of lysophospholipid acid receptor 2. In this study, a novel method that synthesizes DBIBB was developed. In this method, s...

Full description

Saved in:
Bibliographic Details
Published inChemistry of natural compounds Vol. 54; no. 3; pp. 499 - 501
Main Authors Yang, Hong-Peng, Zhang, Shou-Guo, Wang, Gang, Wen, Xiao-Xue, Sun, Yun-Bo, Liu, Shu-Chen, Peng, Tao, Wang, Lin
Format Journal Article
LanguageEnglish
Published New York Springer US 01.05.2018
Springer Nature
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An excellent candidate in the fight against damage caused by nuclear radiation is 2-[4-(1,3-dioxo-1H,3Hbenzoisoquinolin-2-yl)butylsulfamoyl]benzoic acid (DBIBB), a lipid agonist of lysophospholipid acid receptor 2. In this study, a novel method that synthesizes DBIBB was developed. In this method, saccharin was replaced singly by 1,4-dibromobutane, reacted with 1,8-naphthalimide, hydrolyzed by sodium hydroxide, and finally acidified by hydrochloric acid to obtain DBIBB. The new synthesis route was shorter, milder, and simpler than previously reported approaches. The method also produced higher total yield than that of existing ones. Thus, it is applicable to the large-scale synthesis of DBIBB.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0009-3130
1573-8388
DOI:10.1007/s10600-018-2388-x